跳至主要内容
临床试验/NCT07011914
NCT07011914招募中不适用

CARE in MS: Childhood Adversity Research Effort in MS

NYU Langone Health12 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年10月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
12
主要终点
Severity of MS

研究概览

简要总结

This study is structured around three main aims.

In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS).

Aim 2 will investigate the impact of childhood adversity on MS outcomes among individuals with relapsing-remitting MS (RRMS), among whom 70% belong to a group historically under-represented in MS research: Black, Hispanic, or poverty-impacted. Aim 2 procedures involve two visits that include a research blood draw and an MRI scan.

In Aim 3, investigators will conduct interviews and surveys to explore environmental and social factors affecting quality of life for minority MS patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged ≥18-29 years
  • diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS))
  • 70% self-identifying as a Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level) individual,and
  • fluent in English or Spanish.
  • aged ≥18-29 years
  • diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS))
  • 70% self-identifying as a Black, Hispanic, or poverty impacted, and
  • fluent reading in English or Spanish
  • Pediatric onset MS (MS onset before age 18 and age at time of enrollment is 18-25) OR adult-onset MS (MS onset at age 18 or older and age at time of enrollment is 19-29)
  • Disease duration below 8 years
  • Aim 3 will enroll the first 20 participants from Aim 2 who meet the following criteria:
  • completed at least 80% of study data in the cross-sectional study/Aim
  • a total of 70% must self-identify as Black, Hispanic, or meet criteria for poverty impacted.
  • interviews will be evenly split between participants with high (top quartile) and low (bottom quartile) of PROMIS-10 scores.

排除标准

  • Primary or Secondary Progressive MS
  • Inability to consent.
  • MS relapse within 30 days prior to study entry
  • Other major neurologic or psychiatric illness

结局指标

主要结局

Severity of MS

时间窗: Baseline

Severity of MS will be measured by MRI FLAIR lesion volume among Aim 2 participants.

次要结局

  • Age of MS Onset(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验